Mariana Nunes

发表

Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma

N. Vale, Diana Duarte, S. Ricardo, 2022, Cancers.

Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein

G. Almeida, Patrícia M. A. Silva, H. Bousbaa, 2021, Frontiers in Oncology.

Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action

N. Vale, Diana Duarte, S. Ricardo, 2022, Biomolecules.

InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays

S. Ricardo, A. Moreira, Luisa Pereira, 2022, Pathogens.

Recycling the Purpose of Old Drugs to Treat Ovarian Cancer

S. Ricardo, C. Bartosch, Mariana Nunes, 2020, International journal of molecular sciences.

Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation

J. Lopes, V. Heinzelmann-Schwarz, R. Coelho, 2020, Oncogenesis.

The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line

N. Vale, Diana Duarte, S. Ricardo, 2022, International journal of molecular sciences.

Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer

R. Coelho, L. David, S. Ricardo, 2022, International journal of molecular sciences.

Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options

Mariana Nunes, Carla Bartosch, Miguel Henriques Abreu, 2024, Cells.

Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression

R. Dinis-Oliveira, Verónica Ferreira, Diana Luísa Almeida-Nunes, 2024, Biochemistry and Biophysics Reports.